Latest Regulatory Approvals News

Page 158 of 324
Suzerain Investments Holdings Limited has initiated an off-market takeover bid for all remaining shares of Entertainment Rewards Ltd (EAT) at $0.022 per share, a substantial premium over recent trading prices. The offer comes with unanimous support from EAT's Independent Board Committee, subject to regulatory approvals and an independent expert's fairness opinion.
Claire Turing
Claire Turing
28 Oct 2025
Triangle Energy (Global) Limited has amended its quarterly cash flow report to correct key figures while advancing new permits in the Philippines and progressing the transition of its Cliff Head Oil Field to a carbon capture and storage project.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Black Dragon Gold’s latest quarterly report highlights strong local backing for its Salave gold project in Spain, alongside a key director resignation and a stable cash position of CAD$882,000.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.
Ada Torres
Ada Torres
28 Oct 2025
Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.
Ada Torres
Ada Torres
28 Oct 2025
Diatreme Resources reported progress on its Northern Silica Project with key regulatory approvals and metallurgical successes, while agreeing to sell its Clermont Copper/Gold Project to Moonlight Resources, retaining a significant stake.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.
Ada Torres
Ada Torres
28 Oct 2025
Bathurst Resources reported a Q1 FY26 EBITDA of NZD 5.2 million, maintaining full-year guidance and progressing major development projects in New Zealand and Canada.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Bass Oil reported steady quarterly oil production with a 20% increase in Indonesian output following a production enhancement program. The company is poised to enter the East Coast Gas Market pending regulatory approval for the Vanessa gas field acquisition.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Element 25 Limited has raised AU$10 million to advance its Butcherbird Expansion Project in Western Australia, aiming to increase manganese production and support its innovative battery materials refinery in the US.
Maxwell Dee
Maxwell Dee
28 Oct 2025
Alliance Nickel has appointed financial advisors to explore a SPAC transaction for a Nasdaq listing, aiming to tap into premium US capital markets for its NiWest Nickel-Cobalt Project. The move follows a robust feasibility study and a strategic partnership with automaker Stellantis.
Maxwell Dee
Maxwell Dee
28 Oct 2025